Skip to main content

Table 2 Main analysis to compare primary and secondary outcomes for the patients who received 1 and 2 g of ceftriaxone for the treatment of community-onset pneumonia

From: 1g versus 2 g daily intravenous ceftriaxone in the treatment of community onset pneumonia – a propensity score analysis of data from a Japanese multicenter registry

 

1 g

(n = 175)

2 g

(n = 175)

absolute difference

p value

Primary Outcome

 Cure rate (%)

94.6

93.1

1.5 (−3.1, 6.0)

0.009 for non-inferiority, 0.572 for superiority

Secondary Outcomes

 Length of hospital stay (days)

17

26

–9 (−4, −14)

< 0.001

 Duration of antibiotic treatment (days)

8

10

–2 (−1, −3)

0.002

 In-hospital mortality (%)

4.7

4.0

0.7 (−3.6, 5.0)

0.740